Stock Fundamentals

Company Information

Company Name
Haleon plc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
ISIN: US4055521003
CIK: 0001900304
CUSIP: 405552100
Currency: USD
Full Time Employees: 24,535
Phone: 44 1932 959 500
Fiscal Year End: December
IPO Date: Jul 22, 2022
Description:

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Address:

The Heights, Weybridge, United Kingdom, KT13 0NY

Directors & Officers

Name Title Year Born
Mr. Brian James McNamara CEO & Executive Director 1966
Ms. Dawn Amanda Allen CFO & Director 1968
Ms. Claire Dickson Chief Digital & Technology Officer NA
Ms. Joanne Russell Head of Investor Relations NA
Mr. Adrian Charles Morris General Counsel 1967
Ms. Tamara Jane Rogers Chief Marketing Officer 1968
Ms. Line De Decker Chief Human Resources Officer 1974
Mr. Filippo Lanzi President of EMEA & LatAm NA
Mr. Keith Choy President of Asia Pacific 1969
Mr. Bjorn Timelin Head of Strategy NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Dodge & Cox 146.54M Mar 31, 2026 3.29% $0.81 -3.44%
FMR Inc 113.97M Mar 31, 2026 2.56% $0.06 5.58%
ClearBridge Advisors, LLC 31.72M Mar 31, 2026 0.71% $0.28 0.94%
Morgan Stanley - Brokerage Accounts 19.17M Mar 31, 2026 0.43% $0.01 -10.84%
NORGES BANK 16.18M Dec 31, 2025 0.36% $0.02 5,781.82%
Harding Loevner L.P. 15.71M Mar 31, 2026 0.35% $1.62 -5.44%
Harris Associates L.P. 15.03M Mar 31, 2026 0.34% $0.20 0.00%
Arrowstreet Capital Limited Partnership 14.67M Mar 31, 2026 0.33% $0.08 82.81%
Bank of America Corp 10.93M Mar 31, 2026 0.25% $0.01 16.97%
Natixis Advisors, LLC. 9.20M Mar 31, 2026 0.21% $0.13 -8.05%
JONES FINANCIAL COMPANIES LLLP 9.09M Mar 31, 2026 0.20% $0.04 2,454.64%
Nuveen, LLC 8.70M Mar 31, 2026 0.20% $0.02 41.00%
JPMorgan Chase & Co 8.28M Mar 31, 2026 0.19% $0.01 2.21%
Aristotle Capital Management LLC 7.66M Mar 31, 2026 0.17% $0.16 -2.07%
Douglas Lane & Associates, LLC 6.69M Mar 31, 2026 0.15% $0.97 -1.00%
Point72 Asset Management, L.P. 6.57M Mar 31, 2026 0.15% $0.08 38.70%
The Goldman Sachs Group Inc 6.13M Mar 31, 2026 0.14% $0.01 -41.31%
OZ Management LLC 5.30M Mar 31, 2026 0.12% $0.55 -49.30%
BlackRock Inc 5.25M Mar 31, 2026 0.12% $0.00 5.37%
Rockefeller Capital Management L.P. 5.10M Mar 31, 2026 0.11% $0.09 -5.44%

Shares Statistics

Shares Outstanding: 4.41B
Shares Float: 4.43B
% Insiders: 1.40%
% Institutions: 1,325.70%
Short % Float: 0.26%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Dodge & Cox Stock I 107.25M 2.41% ▼ 3.90% Mar 31, 2026
2 Fidelity Series Large Cap Stock 18.24M 0.41% ▲ 12.05% Apr 30, 2026
3 Strategic Advisers Fidelity US TtlStk 14.71M 0.33% ▲ 9.76% Apr 30, 2026
4 Harris International Equity 11.93M 0.27% ▲ 0.00% Mar 31, 2026
5 Oakmark International Investor 11.93M 0.27% ▲ 0.00% Mar 31, 2026
6 Fidelity Growth & Income 11.85M 0.27% ▲ 7.71% Apr 30, 2026
7 Dodge & Cox Balanced I 11.69M 0.26% ▲ 0.00% Mar 31, 2026
8 Dodge & Cox Balanced Composite 11.69M 0.26% ▲ 0.00% Mar 31, 2026
9 Fidelity Large Cap Stock 6.73M 0.15% ▲ 12.03% Apr 30, 2026
10 CREF Total Global Stock Account R3 4.41M 0.10% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $49.71B
Trailing P/E: 18.63
Forward P/E: 17.09

Financial Highlights

Market Cap: $40.31B
EBITDA: $2.74B
P/E Ratio: $18.63
PEG Ratio: $2.41
Book Value: $4.94
Dividend/Share: $0.07
Dividend Yield: 2.11%
Earnings/Share: $0.49
Profit Margin: 15.11%
Operating Margin: 23.17%
ROA (TTM): 4.67%
ROE (TTM): 10.27%
Revenue (TTM): $11.03B
Revenue/Share (TTM): $2.46
Earnings Growth (YOY): 92.00%
Revenue Growth (YOY): 0.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 0.92x 0.52x 0.49x 7.28x 3.08x
2024-12-31 0.98x 0.62x 0.53x 5.60x 3.99x
2023-12-31 1.04x 0.57x 0.51x 4.82x 4.02x
2022-12-31 0.93x 0.64x 0.53x 5.25x 4.78x
2021-12-31 1.24x 0.03x 0.23x 102.38x 0.41x
2020-12-31 1.25x 0.01x 0.23x 62.31x 0.20x
2019-12-31 1.36x 0.02x 0.23x 31.96x 0.44x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about HLN.US!